Connect with MMS

MMS is the leading data-focused CRO dedicated to supporting your needs. To request more information or to speak with a representative from MMS, please use this form and one of our colleagues will contact you shortly.

MMS locations map
North America
MMS Holdings Inc.
6880 Commerce Blvd.
Canton, MI 48187, USA
info@mmsholdings.com
Asia
MMSH Clinical Research Pvt. Ltd.
2/1, Dr. Rajkumar Road,
Rajajinagar
Bangalore 560010, India
Asia@mmsholdings.com
Europe
MMS Holdings Europe Ltd. Spaces Covent Garden
60 St Martins Lane
London, WC2N 4JS
United Kingdom
Europe@mmsholdings.com
South Africa
Postnet Preller Suite 3
Private Bag X01
Heuwelsig 9332, Bloemfontein
South Africa
 SA@mmsholdings.com
Asia
Sonthalia (Dwaraka)
Mindspace, Suite 401,
Madhapur Hyderabad 500081
India
Asia@mmsholdings.com
Europe
Regus House, Harcourt Centre
Harcourt Road, Dublin,
D02 HW77
Republic of Ireland
Europe@mmsholdings.com

Suggested For You

webinar

October 22nd, 2024

Optimal Strategies to Protect Commercially Confidential Information (CCI) in Clinical Documents and Report Trial Results Under Revised EU-CTIS Transparency Rules

perspectives

September 30th, 2024

Meet the Leaders Driving MMS’s European Growth

perspectives

September 30th, 2024

The Future of Data Management and Biostatistics: Trends and Technologies Shaping the Industry

perspectives

September 24th, 2024

Embracing Quality Management Maturity (QMM) at the Cornerstone of the Pharmaceutical Industry

perspectives

September 11th, 2024

From Historical Precedent to Modern Approvals: Lessons Learned on OTC Drug Products for FDA OMORs

webinar

September 26th, 2024

Regulatory Pathways for Nonprescription Drugs: A Deep Dive into OTC Monograph Reform and FDA Guidance

perspectives

September 4th, 2024

Email Security – Navigating Through the Process of Validation and Compliance with Healthcare Business Stakeholders

perspectives

August 27th, 2024

Optimizing Oncology Drug Development: FDA Expedited Pathways, Real-Time Review, and Global Programs

regulatory intelligence

August 27th, 2024

Recent Guidance on Diversity Action Planning

regulatory intelligence

August 26th, 2024

Oncology Programs at the FDA

regulatory intelligence

August 26th, 2024

Three Key Take Reflections on the Recent Donanemab Approval

perspectives

August 20th, 2024

Clinical Study Protocols: A Comprehensive Guide to Best Practices From A Senior Medical Writer